Influence of Huntington's disease on the human and mouse proteome

International Review of Neurobiology

Volumn 61, Issue , 2004, Pages 241-283

  Zabel, Claus ^a   Klose, Joachim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME;

ANIMAL; BRAIN; DISEASE MODEL; HISTOLOGY; HUMAN; HUNTINGTON CHOREA; METABOLISM; METHODOLOGY; MOUSE; PROTEOMICS; REVIEW; TIME;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; HUNTINGTON DISEASE; MICE; PROTEOME; PROTEOMICS; TIME FACTORS;

EID: 16544369609     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(04)61010-5     Document Type: Article

References (96)

1. Arrell, D. K., Neverova, I., and Van Eyk, J. E. (2001). Cardiovascular proteomics: Evolution and potential. Circ. Res. 88, 763-773.
2. Bacchini, A., Gaetani, E., and Cavaggioni, A. (1992). Pheromone binding proteins of the mouse, Mus musculus. Experientia 48, 419-421.
3. Barbour, K. W., Goodwin, R. L., Guillonneau, F., Wang, Y., Baumann, H., and Berger, F. G. (2002). Functional diversification during evolution of the murine alpha(1)-proteinase inhibitor family: Role of the hypervariable reactive center loop. Mol. Biol. Evol. 19, 718-727.
4. Bates, G. (2003). Huntingtin aggregation and toxicity in Huntington's disease. Lancet 361, 1642-1644.
5. Bates, G. P. (2001). Huntington's disease. Exploiting expression. Nature 413, 691, 693-694.
6. Baumann, H., and Gauldie, J. (1994). The acute phase response. Immunol. Today 15, 74-80.
7. Beynon, R. J., and Hurst, J. L. (2003). Multiple roles of major urinary proteins in the house mouse, Mus domesticus. Biochem. Soc. Trans. 31, 142-146.
8. Bhat, S. P., Horwitz, J., Srinivasan, A., and Ding, L. (1991). Alpha B-crystallin exists as an independent protein in the heart and in the lens. Eur. J. Biochem. 202, 775-781.
9. Bhat, S. P., and Nagineni, C. N. (1989). alpha B subunit of lens-specific protein alpha-crystallin is present in other ocular and non-ocular tissues. Biochem. Biophys. Res. Commun. 158, 319-325.
10. Braak, H., Del Tredici, K., Sandmann-Kiel, D., Rub, U., and Schultz, C. (2001). Nerve cells expressing heat-shock proteins in Parkinson's disease. Acta. Neuropathol. (Berl.) 102, 449-454.
11. Brennan, P. A. (2001). The vomeronasal system. Cell Mol. Life Sci. 58, 546-555.
12. Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., et al. (1999). Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19, 3248-3257.
13. Cavaggioni, A., and Mucignat-Caretta, C. (2000). Major urinary proteins, alpha(2U)-globulins and aphrodisin. Biochim. Biophys. Acta 1482, 218-228.
14. Chan, E. Y., Luthi-Carter, R., Strand, A., Solano, S. M., Hanson, S. A., et al. (2002). Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease. Hum. Mol. Genet. 11, 1939-1951.
15. Clissold, P. M., and Bishop, J. O. (1982). Variation in mouse major urinary protein (MUP) genes and the MUP gene products within and between inbred lines. Gene 18, 211-220.
16. Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., et al. (1997). Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548.
17. de Jong, W. W., Leunissen, J. A., and Voorter, C. E. (1993). Evolution of the alpha-crystallin/small heat-shock protein family. Mol. Biol. Ecol. 10, 103-126.
18. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., et al. (1997). Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
19. Dreger, M. (2003). Subcellular proteomics. Mass Spectrom. Rev. 22, 27-56.
20. Dubin, R. A., Wawrousek, E. F., and Piatigorsky, J. (1989). Expression of the murine alpha B-crystallin gene is not restricted to the lens. Mol. Cell Biol. 9, 1083-1091.
21. Dunah, A. W., Jeong, H., Griffin, A., Kim, Y. M., Standaert, D. G., et al. (2002). Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296, 2238-2243.
22. Finotti, P., and Pagetta, A. (1997). Albumin contamination of a purified human alpha 1-antitrypsin preparation does not affect either structural conformation or the electrophoretic mobility of the inhibitor. Clin. Chim. Acta 264, 133-148.
23. Flower, D. R., North, A. C., and Sansom, C. E. (2000). The lipocalin protein family: Structural and sequence overview. Biochim. Biophys. Acta 1482, 9-24.
24. Freiman, R. N., and Tjian, R. (2002). Neurodegeneration. A glutamine-rich trail leads to transcription factors. Science 296, 2149-2150.
25. Gervais, F. G., Singaraja, R., Xanthoudakis, S., Gutekunst, C. A., Leavitt, B. R., et al. (2002). Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat. Cell Biol. 4, 95-105.
26. Glover, J. R., and Lindquist, S. (1998). Hsp104, Hsp70, and Hsp40: A novel chaperone system that rescues previously aggregated proteins. Cell 94, 73-82.
27. Gollin, P. A., Kalaria, R. N., Eikelenboom, P., Rozemuller, A., and Perry, G. (1992). Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease. Neuroreport 3, 201-203.
28. Goodwin, R. L., Barbour, K. W., and Berger, F. G. (1997). Expression of the alpha 1-proteinase inhibitor gene family during evolution of the genus Mus. Mol. Biol. Evol. 14, 420-427.
29. Gusella, J. F., and MacDonald, M. E. (1996). Trinucleotide instability: A repeating theme in human inherited disorders. Annu. Rev. Med. 47, 201-209.
30. Gutekunst, C. A., Li, S. H., Yi, H., Mulroy, J. S., Kuemmerle, S., et al. (1999). Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology. J. Neurosci. 19, 2522-2534.
31. Gygi, S. P., Rist, B., Gerber, S. A., Turecek, F., Gelb, M. H., and Aebersold, R. (1999). Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17, 994-999.
32. Harjes, P., and Wanker, E. E. (2003). The hunt for huntingtin function: Interaction partners tell many different stories. Trends Biochem. Sci. 28, 425-433.
33. HDCRG (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72, 971-983.
34. Huntington, J. A., Read, R. J., and Carrell, R. W. (2000). Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923-926.
35. Hurst, J. L., Payne, C. E., Nevison, C. M., Marie, A. D., Humphries, R. E., et al. (2001). Individual recognition in mice mediated by major urinary proteins. Nature 414, 631-634.
36. Iwaki, T., Kume-Iwaki, A., Liem, R. K., and Goldman, J. E. (1989). Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell 57, 71-78.
37. Jana, N. R., Tanaka, M., Wang, G., and Nukina, N. (2000). Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: Their role in suppression of aggregation and cellular toxicity. Hum. Mol. Genet. 9, 2009-2018.
38. Johnson, J. L., and Craig, E. A. (1997). Protein folding in vivo: Unraveling complex pathways. Cell 90, 201-204.
39. Jungblut, P. R., Zimny-Arndt, U., Zeindl-Eberhart, E., Stulik, J., Koupilova, K., et al. (1999). Proteomics in human disease: cancer, heart and infectious diseases. Electrophoresis 20, 2100-2110.
40. Kalsheker, N., Morley, S., and Morgan, K. (2002). Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin. Biochem. Soc. Trans. 30, 93-98.
41. Kamradt, M. C., Chen, F., and Cryns, V. L. (2001). The small heat shock protein alpha B-crystallin negatively regulates cytochrome c- and caspase-8-dependent activation of caspase-3 by inhibiting its autoproteolytic maturation. J. Biol. Chem. 276, 16059-16063.
42. Kato, K., Ito, H., Kamei, K., Inaguma, Y., Iwamoto, I., and Saga, S. (1998). Phosphorylation of alphaB-crystallin in mitotic cells and identification of enzymatic activities responsible for phosphorylation. J. Biol. Chem. 273, 28346-28354.
43. Klose, J. (1999a). Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis. Methods Mol. Biol. 112, 67-85.
44. Klose, J. (1999b). Genotypes and phenotypes. Electrophoresis 20, 643-652.
45. Klose, J. (1999c). Large-gel 2-D electrophoresis. Methods. Mol. Biol. 112, 147-172.
46. Klose, J., and Kobalz, U. (1995). Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 16, 1034-1059.
47. Koyama, Y., and Goldman, J. E. (1999). Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by alphaB-crystallin. Am. J. Pathol. 154, 1563-1572.
48. Kueppers, F., and Mills, J. (1983). Trypsin inhibition by mouse serum: Sexual dimorphism controlled by testosterone. Science 219, 182-184.
49. Li, H., Li, S. H., Cheng, A. L., Mangiarini, L., Bates, G. P., and Li, X. J. (1999a). Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum. Mol. Genet. 8, 1227-1236.
50. Li, H., Li, S. H., Johnston, H., Shelbourne, P. F., and Li, X. J. (2000). Amino-terminal fragments of mutant huntington show selective accumulation in striatal neurons and synaptic toxicity. Nat. Genet. 25, 385-389.
51. Li, X. P., Pleissner, K. P., Scheler, C., Regitz-Zagrosek, V., Salnikow, J., and Jungblut, P. R. (1999b). A two-dimensional electrophoresis database of rat heart proteins. Electrophoresis 20, 891-897.
52. Lione, L. A., Carter, R. J., Hunt, M. J., Bates, G. P., Morton, A. J., and Dunnett, S. B. (1999). Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci. 19, 10428-10437.
53. Luthi-Carter, R., Hanson, S. A., Strand, A. D., Bergstrom, D. A., Chun, W., et al. (2002a). Dysregulation of gene expression in the R6/2 model of polyglutamine disease: Parallel changes in muscle and brain. Hum. Mol. Genet. 11, 1911-1926.
54. Luthi-Carter, R., Strand, A., Peters, N. L., Solano, S. M., Hollingsworth, Z. R., et al. (2000). Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet. 9, 1259-1271.
55. Luthi-Carter, R., Strand, A. D., Hanson, S. A., Kooperberg, C., Schilling, G., et al. (2002b). Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects. Hum. Mol. Genet. 11, 1927-1937.
56. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., et al. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506.
57. Mao, J. J., Katayama, S., Watanabe, C., Harada, Y., Noda, K., et al. (2001a). The relationship between alphaB-crystallin and neurofibrillary tangles in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 27, 180-188.
58. Mao, Y. W., Xiang, H., Wang, J., Korsmeyer, S., Reddan, J., and Li, D. W. (2001b). Human bcl-2 gene attenuates the ability of rabbit lens epithelial cells against H2O2-induced apoptosis through down-regulation of the alpha B-crystallin gene. J. Biol. Chem. 276, 43435-43445.
59. Marchlewska-Koj, A., Cavaggioni, A., Mucignat-Caretta, C., and Olejniczak, P. (2000). Stimulation of estrus in female mice by male urinary proteins. J. Chem. Ecol. 26, 2355-2366.
60. Mattson, M. P. (2000). Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120-129.
61. McCampbell, A., Taye, A. A., Whitty, L., Penney, E., Steffan, J. S., and Fischbeck, K. H. (2001). Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc. Natl. Acad. Sci. USA 98, 15179-15184.
62. McMurray, S. E., and McMurray, C. T. (2001). Huntington's disease. A sports star and a cook. Lancet 358(Suppl), S38.
63. Molloy, M. P., Brzezinski, E. E., Hang, J., McDowell, M. T., and VanBogelen, R. A. (2003). Overcoming technical variation and biological variation in quantitative proteomics. Proteomics 3, 1912-1919.
64. Muchowski, P. J., Bassuk, J. A., Lubsen, N. H., and Clark, J. I. (1997). Human alphaB-crystallin. Small heat shock protein and molecular chaperone. J. Biol. Chem. 272, 2578-2582.
65. Olanow, C. W., and Tatton, W. G. (1999). Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22, 123-144.
66. Peters, P. J., King, K., Palacios, F., Boshans, R. L., Kazantsev, A., et al. (2002). Arfaptin 2 regulates the aggregation of mutant huntingtin protein. Nat. Cell Biol. 4, 240-245.
67. Pomeroy, S. L., LaMantia, A. S., and Purves, D. (1990). Postnatal construction of neural circuitry in the mouse olfactory bulb. J. Murosci. 10, 1952-1966.
68. Price, D. L., and Sisodia, S. S. (1998). Mutant genes in familial Alzheimer's disease and transgenic models. Annu. Rev. Neurosci. 21, 479-505.
69. Reddy, P. H., Williams, M., Charles, V., Garrett, L., Pike-Buchanan, L., et al. (1998). Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat. Genet. 20, 198-202.
70. Renkawek, K., Stege, G. J., and Bosman, G. J. (1999). Dementia, gliosis and expression of the small heat shock proteins hsp27 and alpha B-crystallin in Parkinson's disease. Neuroreport 10, 2273-2276.
71. Renkawek, K., Voorter, C. E., Bosman, G. J., van Workum, F. P., and de Jong, W. W. (1994). Expression of alpha B-crystallin in Alzheimer's disease. Acta. Neuropathol. (Berl.) 87, 155-160.
72. Santoni, V., Molloy, M., and Rabilloud, T. (2000). Membrane proteins and proteomics: Un amour impossible? Electrophoresis 21, 1054-1070.
73. Sathasivam, K., Hobbs, C., Turmaine, M., Mangiarini, L., Mahal, A., et al. (1999). Formation of polyglutamine inclusions in non-CNS tissue. Hum. Mol. Genet. 8, 813-822.
74. Scheler, C., Lamer, S., Pan, Z., Li, X. P., Salnikow, J., and Jungblut, P. (1998). Peptide mass fingerprint sequence coverage from differently stained proteins on two-dimensional electrophoresis patterns by matrix assisted laser desorption/ionization-mass spectrometry (AULDI-MS). Electrophoresis 19, 918-927.
75. Schilling, G., Becher, M. W., Sharp, A. H., Jinnah, H. A., Duan, K., et al. (1999). Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. 8, 397-407.
76. Seo, E. J., Lee, C., and Yu, M. H. (2002). Concerted regulation of inhibitory activity of alpha 1-antitrypsin by the native strain distributed throughout the molecule. J. Biol. Chem. 277, 14216-14220.
77. Sharp, A. H., and Ross, C. A. (1996). Neurobiology of Huntington's disease. Neurobiol. Dis. 3, 3-15.
78. Silverman, G. A., Bird, P. I., Carrell, R. W., Church, F. C., Coughlin, P. B., et al. (2001). The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293-33296.
79. Sironi, L., Tremoli, E., Miller, I., Guerrini, U., Calvio, A. M., et al. (2001). Acute-phase proteins before cerebral ischemia in stroke-prone rats: Identification by proteomics. Stroke 32, 753-760.
80. Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., et al. (2001). Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Mature 413, 739-743.
81. Swinbanks, D. (1995). Government backs proteome proposal. Nature 378, 653.
82. Takahara, H., and Sinohara, H. (1982). Mouse plasma trypsin inhibitors. Isolation and characterization of alpha-1-antitrypsin and contraspin, a novel trypsin inhibitor. J. Biol. Chem. 257, 2438-2446.
83. Telenius, H., Kremer, H. P., Theilmann, J., Andrew, S. E., Almqvist, E., et al. (1993). Molecular analysis of juvenile Huntington disease: The major influence on (CAG)n repeat length is the sex of the affected parent. Hum. Mol. Genet. 2, 1535-1540.
84. Travis, J., and Salvesen, G. S. (1983). Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52, 655-709.
85. Turmaine, M., Raza, A., Mahal, A., Mangiarini, L., Bates, G. P., and Davies, S. W. (2000). Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc. Natl. Acad. Sci. USA 97, 8093-8097.
86. Velier, J., Kim, M., Schwarz, C., Kim, T. W., Sapp, E., et al. (1998). Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways. Exp. Neurol. 152, 34-40.
87. Vonsattel, J. P., and DiFiglia, M. (1998). Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369-384.
88. Vonsattel, J. P., Myers, R. H., Stevens, T. J., Ferrante, R. J., Bird, E. D., and Richardson, E. P., Jr. (1985). Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577.
89. Wanker, E. E. (2000). Protein aggregation and pathogenesis of Huntington's disease: Mechanisms and correlations. Biol. Chem. 381, 937-942.
90. Wicks, L. F. (1941). Sex and proteinuria of mice. Proc. Soc. Exp. Biol. Med. 48, 395-400.
91. Yamamoto, K., and Sinohara, H. (1984). Regulation by sex hormones of serum levels of contrapsin and alpha 1-antiprotease in the mouse. Biochim. Biophys. Acta 798, 231-234.
92. Zabel, C. (2003). Veränderungen im Proteom von Maus und Mensch durch Huntington's Chorea. Ph. D. Thesis.
93. Zabel, C., Chamrad, D. C., Priller, J., Woodman, B., Meyer, H. E., et al. (2002). Alterations in the mouse and human proteome caused by Huntington's disease. Mol. Cell Proteomics 1, 366-375.
94. Zoghbi, H. Y., and Orr, H. T. (2000). Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23, 217-247.
95. Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., et al. (2001). Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293, 493-498.
96. Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., et al. (2003). Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 35, 76-83.